LCN2 and acute kidney injury: Neutrophil gelatinase-associated lipocalin has also been demonstrated as a reliable diagnostic biomarker of AKI within the clinical context of systemic inflammation in critical illness, accurately predicting the development of AKI in patients with sepsis regardless of its severity (categorized by serum procalcitonin concentration) (37).